Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

New Canadian patent approval for Episurf Medical

Episurf Medical
Download the release

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the Canadian Intellectual Property Office (CIPO). The patent, entitled "System and method for creating a decision support material indicating damage to an anatomical joint", relates to 3D-based assessment of joint lesions. 

"This is an important patent for Episurf in the field of medical imaging and surgical pre-planning, and we are happy to get it approved in strategically selected countries", says Katarina Flodström, COO, Episurf Medical.  

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.